M4MM

DEA Schedules Cannabis Rescheduling Hearings for Early 2025

LOS ANGELES- The Drug Enforcement Administration (DEA) has outlined a schedule for witness testimony in the ongoing hearing concerning the potential reclassification of cannabis under the Controlled Substances Act. Chief Administrative Law Judge John Mulrooney ...

DEA Schedules Cannabis Rescheduling Hearings for Early 2025

LOS ANGELES- The Drug Enforcement Administration (DEA) has outlined a schedule for witness testimony in the ongoing hearing concerning the potential reclassification of cannabis under the Controlled Substances Act. Chief Administrative Law Judge John Mulrooney ...

Entheon Biomedical Uplists on OTCQB Venture Market

VANCOUVER, B.C.– Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: "1XU1"), a biotechnology company focused on developing psychedelic medicines to treat addiction, announces it has been approved for trading on the OTCQB Venture Market effective ...

Subscribe To Our Newsletter